LipoScience sets IPO range

Cardiovascular diagnostic company LipoScience Inc. (Raleigh, N.C.) amended its IPO and now plans to sell 5 million shares at $13-$15 per share. At the mid-point of $14, LipoScience would raise $70 million and be valued at $194.4 million. In June 2011, the company proposed to raise up to $86.3 million in an IPO underwritten by Barclays; UBS; and Piper Jaffray (see BioCentury, June 27, 2011). ...